

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | modulation by symbiont of host defense response (GO:0052031) | 6.43547844 |
| 2 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 6.43547844 |
| 3 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 6.43547844 |
| 4 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 6.43547844 |
| 5 | modulation by symbiont of host immune response (GO:0052553) | 6.43547844 |
| 6 | positive regulation by symbiont of host defense response (GO:0052509) | 6.43547844 |
| 7 | neutrophil activation involved in immune response (GO:0002283) | 5.36093840 |
| 8 | response to peptidoglycan (GO:0032494) | 5.05697427 |
| 9 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.86346668 |
| 10 | detection of bacterium (GO:0016045) | 4.76485171 |
| 11 | response to host immune response (GO:0052572) | 4.67230104 |
| 12 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.67230104 |
| 13 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.60223139 |
| 14 | leukocyte aggregation (GO:0070486) | 4.52739570 |
| 15 | macrophage activation involved in immune response (GO:0002281) | 4.52472554 |
| 16 | respiratory burst (GO:0045730) | 4.38479085 |
| 17 | cellular extravasation (GO:0045123) | 4.38065868 |
| 18 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 4.33250159 |
| 19 | response to host (GO:0075136) | 4.33250159 |
| 20 | response to host defenses (GO:0052200) | 4.33250159 |
| 21 | positive regulation of interferon-alpha production (GO:0032727) | 4.31228443 |
| 22 | detection of external biotic stimulus (GO:0098581) | 4.25496301 |
| 23 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.19992972 |
| 24 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.17256481 |
| 25 | negative regulation of cell killing (GO:0031342) | 4.16780973 |
| 26 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.16780973 |
| 27 | regulation of interferon-alpha production (GO:0032647) | 4.10751448 |
| 28 | immunoglobulin mediated immune response (GO:0016064) | 4.06165769 |
| 29 | response to muramyl dipeptide (GO:0032495) | 4.04363322 |
| 30 | neutrophil activation (GO:0042119) | 4.00896286 |
| 31 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.94401943 |
| 32 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.93480120 |
| 33 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.93392549 |
| 34 | granulocyte activation (GO:0036230) | 3.93229495 |
| 35 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.87708054 |
| 36 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.87708054 |
| 37 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.83128685 |
| 38 | neutrophil mediated immunity (GO:0002446) | 3.82327224 |
| 39 | detection of biotic stimulus (GO:0009595) | 3.74669584 |
| 40 | positive regulation of antigen processing and presentation (GO:0002579) | 3.68154005 |
| 41 | negative regulation of interleukin-12 production (GO:0032695) | 3.61737124 |
| 42 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.58085253 |
| 43 | myeloid cell activation involved in immune response (GO:0002275) | 3.57134846 |
| 44 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.53029231 |
| 45 | positive regulation of mast cell activation (GO:0033005) | 3.51437401 |
| 46 | response to fungus (GO:0009620) | 3.49310577 |
| 47 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.46151068 |
| 48 | regulation of mast cell degranulation (GO:0043304) | 3.45997669 |
| 49 | negative regulation of T cell mediated immunity (GO:0002710) | 3.44188653 |
| 50 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.38217657 |
| 51 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.35494961 |
| 52 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.34975125 |
| 53 | response to interleukin-15 (GO:0070672) | 3.34650439 |
| 54 | leukocyte cell-cell adhesion (GO:0007159) | 3.29660747 |
| 55 | regulation of leukocyte degranulation (GO:0043300) | 3.26285431 |
| 56 | microglial cell activation (GO:0001774) | 3.24897066 |
| 57 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.24764472 |
| 58 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.23527299 |
| 59 | regulation of mast cell activation (GO:0033003) | 3.22864458 |
| 60 | regulation of T cell tolerance induction (GO:0002664) | 3.22648342 |
| 61 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.21536775 |
| 62 | defense response to protozoan (GO:0042832) | 3.20898605 |
| 63 | pinocytosis (GO:0006907) | 3.20132573 |
| 64 | regulation of tolerance induction (GO:0002643) | 3.17244908 |
| 65 | regulation of antigen processing and presentation (GO:0002577) | 3.16877645 |
| 66 | positive regulation of B cell differentiation (GO:0045579) | 3.15452283 |
| 67 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.15000303 |
| 68 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.13419813 |
| 69 | regulation of regulated secretory pathway (GO:1903305) | 3.11849399 |
| 70 | leukocyte degranulation (GO:0043299) | 3.11685716 |
| 71 | response to type I interferon (GO:0034340) | 3.11685313 |
| 72 | macrophage activation (GO:0042116) | 3.10405378 |
| 73 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.08658937 |
| 74 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.08253953 |
| 75 | detection of molecule of bacterial origin (GO:0032490) | 3.08137882 |
| 76 | cellular response to type I interferon (GO:0071357) | 3.07868607 |
| 77 | type I interferon signaling pathway (GO:0060337) | 3.07868607 |
| 78 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.07568128 |
| 79 | positive regulation of interferon-beta production (GO:0032728) | 3.07515579 |
| 80 | positive regulation of mast cell degranulation (GO:0043306) | 3.07508229 |
| 81 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.07508229 |
| 82 | cellular response to interleukin-15 (GO:0071350) | 3.05832043 |
| 83 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.04878969 |
| 84 | neutrophil chemotaxis (GO:0030593) | 3.04203514 |
| 85 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.03859209 |
| 86 | leukotriene metabolic process (GO:0006691) | 3.02970057 |
| 87 | regulation of integrin activation (GO:0033623) | 3.02540508 |
| 88 | germinal center formation (GO:0002467) | 3.02063050 |
| 89 | I-kappaB phosphorylation (GO:0007252) | 3.00677785 |
| 90 | B cell mediated immunity (GO:0019724) | 2.99631995 |
| 91 | B cell receptor signaling pathway (GO:0050853) | 2.98655760 |
| 92 | response to protozoan (GO:0001562) | 2.98596715 |
| 93 | T-helper 1 type immune response (GO:0042088) | 2.97752103 |
| 94 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.96971591 |
| 95 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.96784671 |
| 96 | natural killer cell mediated immunity (GO:0002228) | 2.96784671 |
| 97 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.95752298 |
| 98 | neutrophil migration (GO:1990266) | 2.95045400 |
| 99 | leukocyte mediated cytotoxicity (GO:0001909) | 2.93014440 |
| 100 | negative regulation of innate immune response (GO:0045824) | 2.92245161 |
| 101 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.91439484 |
| 102 | myeloid leukocyte mediated immunity (GO:0002444) | 2.89885756 |
| 103 | negative regulation of interleukin-6 production (GO:0032715) | 2.87368533 |
| 104 | mannose metabolic process (GO:0006013) | 2.86586809 |
| 105 | response to interferon-alpha (GO:0035455) | 2.85561592 |
| 106 | superoxide anion generation (GO:0042554) | 2.84643606 |
| 107 | apoptotic cell clearance (GO:0043277) | 2.84106700 |
| 108 | regulation of B cell differentiation (GO:0045577) | 2.83768900 |
| 109 | negative regulation of type 2 immune response (GO:0002829) | 2.82367948 |
| 110 | positive regulation of leukocyte degranulation (GO:0043302) | 2.79683888 |
| 111 | defense response to fungus (GO:0050832) | 2.79131918 |
| 112 | regulation of gamma-delta T cell activation (GO:0046643) | 2.78854513 |
| 113 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.78504531 |
| 114 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.77870226 |
| 115 | dendritic cell chemotaxis (GO:0002407) | 2.77389834 |
| 116 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.76411062 |
| 117 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.75585391 |
| 118 | detection of other organism (GO:0098543) | 2.74953030 |
| 119 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.74536794 |
| 120 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.74196353 |
| 121 | regulation of phagocytosis (GO:0050764) | 2.73735314 |
| 122 | myeloid leukocyte activation (GO:0002274) | 2.72510467 |
| 123 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.71537663 |
| 124 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.71175232 |
| 125 | actin nucleation (GO:0045010) | 2.70371118 |
| 126 | reactive oxygen species biosynthetic process (GO:1903409) | 2.68335966 |
| 127 | negative regulation of granulocyte differentiation (GO:0030853) | 2.67307683 |
| 128 | negative regulation of phagocytosis (GO:0050765) | 2.66223044 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.72157407 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.84453444 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.80281933 |
| 4 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.98856314 |
| 5 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.96095122 |
| 6 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.68296016 |
| 7 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.64582876 |
| 8 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.54381033 |
| 9 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.52115975 |
| 10 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.33941085 |
| 11 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.08119488 |
| 12 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.01787328 |
| 13 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.99066721 |
| 14 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.97258651 |
| 15 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.74085722 |
| 16 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.69589806 |
| 17 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.67843813 |
| 18 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.53289264 |
| 19 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.52289063 |
| 20 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.51940580 |
| 21 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.43054633 |
| 22 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.39688382 |
| 23 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.24360008 |
| 24 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.24209771 |
| 25 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.24170597 |
| 26 | SPI1_23127762_ChIP-Seq_K562_Human | 2.16905693 |
| 27 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.16103468 |
| 28 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.06061109 |
| 29 | MAF_26560356_Chip-Seq_TH1_Human | 2.05057437 |
| 30 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.99131118 |
| 31 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.98231581 |
| 32 | MYB_26560356_Chip-Seq_TH2_Human | 1.97152851 |
| 33 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.93735120 |
| 34 | MYC_22102868_ChIP-Seq_BL_Human | 1.93459591 |
| 35 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.83787879 |
| 36 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.77411885 |
| 37 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.76894638 |
| 38 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.76179530 |
| 39 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.76001529 |
| 40 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.72787131 |
| 41 | MYB_26560356_Chip-Seq_TH1_Human | 1.72402098 |
| 42 | UTX_26944678_Chip-Seq_JUKART_Human | 1.67739036 |
| 43 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.66391541 |
| 44 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.63599648 |
| 45 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.58704881 |
| 46 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.54507282 |
| 47 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.53915090 |
| 48 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.51666359 |
| 49 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.50631181 |
| 50 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.47209250 |
| 51 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.46771755 |
| 52 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.46474838 |
| 53 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.41537369 |
| 54 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.39542345 |
| 55 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.39093065 |
| 56 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.37500403 |
| 57 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.35340544 |
| 58 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.33878845 |
| 59 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.30265345 |
| 60 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.28844806 |
| 61 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.28815568 |
| 62 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.27542574 |
| 63 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.26703401 |
| 64 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.26652991 |
| 65 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.25949908 |
| 66 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.23557436 |
| 67 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22771971 |
| 68 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.21908808 |
| 69 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.20294683 |
| 70 | MAF_26560356_Chip-Seq_TH2_Human | 1.20190179 |
| 71 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.18519801 |
| 72 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.17463679 |
| 73 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.16501185 |
| 74 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.15944282 |
| 75 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.14458025 |
| 76 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.12862596 |
| 77 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.12227056 |
| 78 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.11956860 |
| 79 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.11429625 |
| 80 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.09836888 |
| 81 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.08093825 |
| 82 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.07579934 |
| 83 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.05551877 |
| 84 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.05292966 |
| 85 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.05062393 |
| 86 | GATA3_26560356_Chip-Seq_TH2_Human | 1.04759454 |
| 87 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.02955455 |
| 88 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.99749087 |
| 89 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.99601084 |
| 90 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.97533642 |
| 91 | GATA2_19941826_ChIP-Seq_K562_Human | 0.96916903 |
| 92 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95556178 |
| 93 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.94556060 |
| 94 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.94083964 |
| 95 | GATA1_19941826_ChIP-Seq_K562_Human | 0.93608886 |
| 96 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.92298958 |
| 97 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.91516477 |
| 98 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.90341027 |
| 99 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.89882379 |
| 100 | GATA1_22025678_ChIP-Seq_K562_Human | 0.89656360 |
| 101 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.89064077 |
| 102 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.89059898 |
| 103 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.88104122 |
| 104 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87209536 |
| 105 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.86561113 |
| 106 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.85352114 |
| 107 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.83958754 |
| 108 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.81626330 |
| 109 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.79889422 |
| 110 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.78273774 |
| 111 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.77318551 |
| 112 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.74478662 |
| 113 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.72078980 |
| 114 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.72078980 |
| 115 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.71979045 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 4.02513999 |
| 2 | MP0003436_decreased_susceptibility_to | 3.90347113 |
| 3 | MP0005058_abnormal_lysosome_morphology | 3.43105319 |
| 4 | MP0001835_abnormal_antigen_presentation | 3.40809314 |
| 5 | MP0002419_abnormal_innate_immunity | 3.07343451 |
| 6 | MP0009785_altered_susceptibility_to | 2.90426596 |
| 7 | MP0005000_abnormal_immune_tolerance | 2.72143572 |
| 8 | MP0005025_abnormal_response_to | 2.66573382 |
| 9 | MP0006082_CNS_inflammation | 2.65654199 |
| 10 | MP0005387_immune_system_phenotype | 2.64830693 |
| 11 | MP0001790_abnormal_immune_system | 2.64830693 |
| 12 | MP0009278_abnormal_bone_marrow | 2.62325431 |
| 13 | MP0000685_abnormal_immune_system | 2.61959755 |
| 14 | MP0003172_abnormal_lysosome_physiology | 2.53308031 |
| 15 | MP0002452_abnormal_antigen_presenting | 2.45573629 |
| 16 | MP0004510_myositis | 2.44532333 |
| 17 | MP0002148_abnormal_hypersensitivity_rea | 2.44213427 |
| 18 | MP0005464_abnormal_platelet_physiology | 2.41663795 |
| 19 | MP0001800_abnormal_humoral_immune | 2.37219503 |
| 20 | MP0003724_increased_susceptibility_to | 2.32336314 |
| 21 | MP0003300_gastrointestinal_ulcer | 2.29575313 |
| 22 | MP0002723_abnormal_immune_serum | 2.24800491 |
| 23 | MP0000569_abnormal_digit_pigmentation | 2.24038135 |
| 24 | MP0001533_abnormal_skeleton_physiology | 2.23934225 |
| 25 | MP0001819_abnormal_immune_cell | 2.16983285 |
| 26 | MP0002420_abnormal_adaptive_immunity | 2.15730825 |
| 27 | MP0004947_skin_inflammation | 2.08505029 |
| 28 | MP0005671_abnormal_response_to | 2.08435538 |
| 29 | MP0003183_abnormal_peptide_metabolism | 2.06404440 |
| 30 | MP0002405_respiratory_system_inflammati | 1.98506116 |
| 31 | MP0003448_altered_tumor_morphology | 1.90310316 |
| 32 | MP0001545_abnormal_hematopoietic_system | 1.79662174 |
| 33 | MP0005397_hematopoietic_system_phenotyp | 1.79662174 |
| 34 | MP0009840_abnormal_foam_cell | 1.78631768 |
| 35 | MP0001845_abnormal_inflammatory_respons | 1.77531916 |
| 36 | MP0000343_altered_response_to | 1.72088059 |
| 37 | MP0005451_abnormal_body_composition | 1.69880592 |
| 38 | MP0003566_abnormal_cell_adhesion | 1.65053364 |
| 39 | MP0002398_abnormal_bone_marrow | 1.63296819 |
| 40 | MP0000716_abnormal_immune_system | 1.62528202 |
| 41 | MP0002132_abnormal_respiratory_system | 1.61326655 |
| 42 | MP0010307_abnormal_tumor_latency | 1.58122911 |
| 43 | MP0001853_heart_inflammation | 1.57080021 |
| 44 | MP0009333_abnormal_splenocyte_physiolog | 1.54318486 |
| 45 | MP0003075_altered_response_to | 1.52849127 |
| 46 | MP0005076_abnormal_cell_differentiation | 1.52587562 |
| 47 | MP0000465_gastrointestinal_hemorrhage | 1.49567105 |
| 48 | MP0001851_eye_inflammation | 1.47114089 |
| 49 | MP0008469_abnormal_protein_level | 1.46893356 |
| 50 | MP0000689_abnormal_spleen_morphology | 1.46341232 |
| 51 | MP0010155_abnormal_intestine_physiology | 1.46309805 |
| 52 | MP0000858_altered_metastatic_potential | 1.45669354 |
| 53 | MP0004808_abnormal_hematopoietic_stem | 1.43592670 |
| 54 | MP0002396_abnormal_hematopoietic_system | 1.40092782 |
| 55 | MP0005174_abnormal_tail_pigmentation | 1.39949240 |
| 56 | MP0002166_altered_tumor_susceptibility | 1.37838598 |
| 57 | MP0003191_abnormal_cellular_cholesterol | 1.36248844 |
| 58 | MP0002429_abnormal_blood_cell | 1.36088823 |
| 59 | MP0002722_abnormal_immune_system | 1.35490910 |
| 60 | MP0000604_amyloidosis | 1.33375823 |
| 61 | MP0003705_abnormal_hypodermis_morpholog | 1.29653458 |
| 62 | MP0002933_joint_inflammation | 1.26536284 |
| 63 | MP0002998_abnormal_bone_remodeling | 1.23039125 |
| 64 | MP0005310_abnormal_salivary_gland | 1.22890775 |
| 65 | MP0001873_stomach_inflammation | 1.20421887 |
| 66 | MP0005023_abnormal_wound_healing | 1.18988451 |
| 67 | MP0002006_tumorigenesis | 1.16376792 |
| 68 | MP0009764_decreased_sensitivity_to | 1.13070368 |
| 69 | MP0005390_skeleton_phenotype | 1.09047827 |
| 70 | MP0008004_abnormal_stomach_pH | 1.08980154 |
| 71 | MP0003806_abnormal_nucleotide_metabolis | 1.06935274 |
| 72 | MP0000490_abnormal_crypts_of | 1.03394752 |
| 73 | MP0003828_pulmonary_edema | 1.00787002 |
| 74 | MP0005166_decreased_susceptibility_to | 1.00039363 |
| 75 | MP0010352_gastrointestinal_tract_polyps | 0.99319246 |
| 76 | MP0003453_abnormal_keratinocyte_physiol | 0.98190677 |
| 77 | MP0008438_abnormal_cutaneous_collagen | 0.97708270 |
| 78 | MP0004381_abnormal_hair_follicle | 0.97635479 |
| 79 | MP0001958_emphysema | 0.95588013 |
| 80 | MP0003091_abnormal_cell_migration | 0.93930438 |
| 81 | MP0009763_increased_sensitivity_to | 0.92663093 |
| 82 | MP0008260_abnormal_autophagy | 0.88252394 |
| 83 | MP0003690_abnormal_glial_cell | 0.87464511 |
| 84 | MP0003656_abnormal_erythrocyte_physiolo | 0.83764041 |
| 85 | MP0000703_abnormal_thymus_morphology | 0.83481187 |
| 86 | MP0000249_abnormal_blood_vessel | 0.82679439 |
| 87 | MP0005164_abnormal_response_to | 0.82572721 |
| 88 | MP0002138_abnormal_hepatobiliary_system | 0.81479048 |
| 89 | MP0000015_abnormal_ear_pigmentation | 0.79186427 |
| 90 | MP0003763_abnormal_thymus_physiology | 0.75594287 |
| 91 | MP0000371_diluted_coat_color | 0.73660312 |
| 92 | MP0002877_abnormal_melanocyte_morpholog | 0.73065788 |
| 93 | MP0003795_abnormal_bone_structure | 0.72541970 |
| 94 | MP0009765_abnormal_xenobiotic_induced | 0.71339896 |
| 95 | MP0005167_abnormal_blood-brain_barrier | 0.70339360 |
| 96 | MP0002254_reproductive_system_inflammat | 0.69084005 |
| 97 | MP0000767_abnormal_smooth_muscle | 0.68405120 |
| 98 | MP0004883_abnormal_blood_vessel | 0.67863884 |
| 99 | MP0003045_fibrosis | 0.66790759 |
| 100 | MP0001663_abnormal_digestive_system | 0.63981195 |
| 101 | MP0001881_abnormal_mammary_gland | 0.63690573 |
| 102 | MP0001986_abnormal_taste_sensitivity | 0.63327717 |
| 103 | MP0005257_abnormal_intraocular_pressure | 0.62586589 |
| 104 | MP0008874_decreased_physiological_sensi | 0.62420449 |
| 105 | MP0002277_abnormal_respiratory_mucosa | 0.62195209 |
| 106 | MP0005319_abnormal_enzyme/_coenzyme | 0.60734326 |
| 107 | MP0000920_abnormal_myelination | 0.60648799 |
| 108 | MP0003279_aneurysm | 0.59877124 |
| 109 | MP0002019_abnormal_tumor_incidence | 0.59362224 |
| 110 | MP0003866_abnormal_defecation | 0.58898745 |
| 111 | MP0005621_abnormal_cell_physiology | 0.56085918 |
| 112 | MP0005381_digestive/alimentary_phenotyp | 0.55741045 |
| 113 | MP0001915_intracranial_hemorrhage | 0.54803472 |
| 114 | MP0005075_abnormal_melanosome_morpholog | 0.54673620 |
| 115 | MP0002332_abnormal_exercise_endurance | 0.53407453 |
| 116 | MP0003329_amyloid_beta_deposits | 0.52474420 |
| 117 | MP0005083_abnormal_biliary_tract | 0.51300156 |
| 118 | MP0000609_abnormal_liver_physiology | 0.49040153 |
| 119 | MP0003221_abnormal_cardiomyocyte_apopto | 0.47324919 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 6.99022991 |
| 2 | Eczematoid dermatitis (HP:0000976) | 6.71686087 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 6.24320021 |
| 4 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.69225055 |
| 5 | Abnormality of macrophages (HP:0004311) | 5.18447674 |
| 6 | Vacuolated lymphocytes (HP:0001922) | 4.42988333 |
| 7 | Systemic lupus erythematosus (HP:0002725) | 4.41695263 |
| 8 | Increased cerebral lipofuscin (HP:0011813) | 4.29766279 |
| 9 | Myositis (HP:0100614) | 4.23928147 |
| 10 | Mediastinal lymphadenopathy (HP:0100721) | 4.03050807 |
| 11 | Obstructive lung disease (HP:0006536) | 3.88699743 |
| 12 | Chronic obstructive pulmonary disease (HP:0006510) | 3.88699743 |
| 13 | Recurrent skin infections (HP:0001581) | 3.86034356 |
| 14 | Recurrent fungal infections (HP:0002841) | 3.81889962 |
| 15 | Orchitis (HP:0100796) | 3.81470407 |
| 16 | Gingivitis (HP:0000230) | 3.78550821 |
| 17 | Gastrointestinal infarctions (HP:0005244) | 3.75451672 |
| 18 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.75137223 |
| 19 | Dysostosis multiplex (HP:0000943) | 3.65976688 |
| 20 | Encephalitis (HP:0002383) | 3.46236471 |
| 21 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.42950553 |
| 22 | Retrobulbar optic neuritis (HP:0100654) | 3.41376983 |
| 23 | Optic neuritis (HP:0100653) | 3.41376983 |
| 24 | Hypochromic microcytic anemia (HP:0004840) | 3.29507284 |
| 25 | Pustule (HP:0200039) | 3.19519798 |
| 26 | Stomatitis (HP:0010280) | 3.08682497 |
| 27 | Cellulitis (HP:0100658) | 3.06639538 |
| 28 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.04698140 |
| 29 | Mucopolysacchariduria (HP:0008155) | 3.04698140 |
| 30 | Abnormality of glycolipid metabolism (HP:0010969) | 3.02395133 |
| 31 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.02395133 |
| 32 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.02395133 |
| 33 | Disinhibition (HP:0000734) | 2.96605312 |
| 34 | Periodontitis (HP:0000704) | 2.96515955 |
| 35 | Hypochromic anemia (HP:0001931) | 2.94634957 |
| 36 | Amyloidosis (HP:0011034) | 2.92142677 |
| 37 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.91263558 |
| 38 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.91263558 |
| 39 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.91263558 |
| 40 | Recurrent viral infections (HP:0004429) | 2.89586860 |
| 41 | Autoimmune thrombocytopenia (HP:0001973) | 2.89512808 |
| 42 | Axonal loss (HP:0003447) | 2.86420797 |
| 43 | Glomerulonephritis (HP:0000099) | 2.85552362 |
| 44 | Urticaria (HP:0001025) | 2.85103785 |
| 45 | Episodic fever (HP:0001954) | 2.83770435 |
| 46 | Spontaneous hematomas (HP:0007420) | 2.81654125 |
| 47 | Loss of speech (HP:0002371) | 2.76929684 |
| 48 | Vasculitis (HP:0002633) | 2.73376098 |
| 49 | Meningitis (HP:0001287) | 2.71497306 |
| 50 | Arterial thrombosis (HP:0004420) | 2.71169604 |
| 51 | T lymphocytopenia (HP:0005403) | 2.65392462 |
| 52 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.64646266 |
| 53 | Recurrent cutaneous fungal infections (HP:0011370) | 2.64646266 |
| 54 | Interstitial pulmonary disease (HP:0006530) | 2.57864566 |
| 55 | Abnormality of T cell number (HP:0011839) | 2.56826660 |
| 56 | Osteolytic defects of the hand bones (HP:0009699) | 2.56047900 |
| 57 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.56047900 |
| 58 | Anorexia (HP:0002039) | 2.55033552 |
| 59 | Hematochezia (HP:0002573) | 2.50905290 |
| 60 | Increased IgM level (HP:0003496) | 2.50883221 |
| 61 | Osteomyelitis (HP:0002754) | 2.49488912 |
| 62 | Gingival bleeding (HP:0000225) | 2.47940149 |
| 63 | Purpura (HP:0000979) | 2.45221764 |
| 64 | Prolonged bleeding time (HP:0003010) | 2.44991571 |
| 65 | Chronic otitis media (HP:0000389) | 2.43644619 |
| 66 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.43258643 |
| 67 | Nasal polyposis (HP:0100582) | 2.39028239 |
| 68 | IgM deficiency (HP:0002850) | 2.36542142 |
| 69 | Prostate neoplasm (HP:0100787) | 2.35382712 |
| 70 | Leukocytosis (HP:0001974) | 2.35012419 |
| 71 | Increased serum ferritin (HP:0003281) | 2.32928818 |
| 72 | Microcytic anemia (HP:0001935) | 2.31115049 |
| 73 | Abnormality of T cells (HP:0002843) | 2.30798693 |
| 74 | Myocardial infarction (HP:0001658) | 2.30625209 |
| 75 | Inflammation of the large intestine (HP:0002037) | 2.28658917 |
| 76 | Granulocytopenia (HP:0001913) | 2.28369288 |
| 77 | J-shaped sella turcica (HP:0002680) | 2.28332184 |
| 78 | Abnormality of the nasal mucosa (HP:0000433) | 2.27250179 |
| 79 | Hypergammaglobulinemia (HP:0010702) | 2.26718547 |
| 80 | Thoracic kyphosis (HP:0002942) | 2.25832554 |
| 81 | Petechiae (HP:0000967) | 2.23888422 |
| 82 | Pulmonary infiltrates (HP:0002113) | 2.23332034 |
| 83 | Panhypogammaglobulinemia (HP:0003139) | 2.22962982 |
| 84 | Gangrene (HP:0100758) | 2.20680385 |
| 85 | Epistaxis (HP:0000421) | 2.19668380 |
| 86 | Abnormality of the pleura (HP:0002103) | 2.18755052 |
| 87 | Gastrointestinal inflammation (HP:0004386) | 2.17140440 |
| 88 | Basal ganglia calcification (HP:0002135) | 2.16687904 |
| 89 | Abnormality of iron homeostasis (HP:0011031) | 2.16613210 |
| 90 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.15662567 |
| 91 | Agnosia (HP:0010524) | 2.15520873 |
| 92 | Thick nail (HP:0001805) | 2.15420969 |
| 93 | Premature loss of primary teeth (HP:0006323) | 2.14893636 |
| 94 | Nephritis (HP:0000123) | 2.14476897 |
| 95 | Sepsis (HP:0100806) | 2.14424945 |
| 96 | Keratoconjunctivitis sicca (HP:0001097) | 2.14031298 |
| 97 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.13366429 |
| 98 | Peritonitis (HP:0002586) | 2.11021127 |
| 99 | Increased IgE level (HP:0003212) | 2.10744447 |
| 100 | Hepatosplenomegaly (HP:0001433) | 2.10529229 |
| 101 | Lymphopenia (HP:0001888) | 2.09898397 |
| 102 | Increased density of long bones (HP:0006392) | 2.09459918 |
| 103 | Colitis (HP:0002583) | 2.06608441 |
| 104 | Menorrhagia (HP:0000132) | 2.06424134 |
| 105 | Hemoptysis (HP:0002105) | 2.06058209 |
| 106 | Abnormality of the lumbar spine (HP:0100712) | 2.06056007 |
| 107 | Abnormal platelet function (HP:0011869) | 2.06030814 |
| 108 | Impaired platelet aggregation (HP:0003540) | 2.06030814 |
| 109 | Absent frontal sinuses (HP:0002688) | 2.04524517 |
| 110 | Glomerulopathy (HP:0100820) | 2.04346809 |
| 111 | Acne (HP:0001061) | 2.00589593 |
| 112 | Abnormality of T cell physiology (HP:0011840) | 1.99033517 |
| 113 | Abnormality of the endocardium (HP:0004306) | 1.98723841 |
| 114 | Abnormality of the peritoneum (HP:0002585) | 1.98660986 |
| 115 | Abnormality of complement system (HP:0005339) | 1.98461403 |
| 116 | Polycythemia (HP:0001901) | 1.97753433 |
| 117 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.97620276 |
| 118 | Abnormal platelet volume (HP:0011876) | 1.96929669 |
| 119 | Cervical subluxation (HP:0003308) | 1.96730267 |
| 120 | Recurrent pneumonia (HP:0006532) | 1.96707271 |
| 121 | Spondylolisthesis (HP:0003302) | 1.96128256 |
| 122 | Pathologic fracture (HP:0002756) | 1.95082054 |
| 123 | Vertigo (HP:0002321) | 1.94676179 |
| 124 | Polyneuropathy (HP:0001271) | 1.93293209 |
| 125 | Keratoconjunctivitis (HP:0001096) | 1.92530115 |
| 126 | Malnutrition (HP:0004395) | 1.92099512 |
| 127 | Cerebral aneurysm (HP:0004944) | 1.90610836 |
| 128 | Abnormality of the pericardium (HP:0001697) | 1.89704434 |
| 129 | Chest pain (HP:0100749) | 1.89171340 |
| 130 | Abnormality of the thoracic spine (HP:0100711) | 1.88802683 |
| 131 | Deformed sella turcica (HP:0002681) | 1.86657586 |
| 132 | Skin ulcer (HP:0200042) | 1.83947475 |
| 133 | Vertebral compression fractures (HP:0002953) | 1.81803278 |
| 134 | Pulmonary embolism (HP:0002204) | 1.80258443 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRAK4 | 3.38933033 |
| 2 | MAP4K1 | 3.30356872 |
| 3 | BLK | 2.97257703 |
| 4 | RIPK4 | 2.77511910 |
| 5 | TYK2 | 2.67567940 |
| 6 | TBK1 | 2.66387878 |
| 7 | ERN1 | 2.55798650 |
| 8 | KIT | 2.54935776 |
| 9 | EPHB1 | 2.52334831 |
| 10 | PRPF4B | 2.35273656 |
| 11 | MAP3K14 | 2.33478223 |
| 12 | TRIB3 | 2.30112287 |
| 13 | FES | 2.17891028 |
| 14 | IRAK3 | 2.16173790 |
| 15 | PKN2 | 2.12238658 |
| 16 | STK10 | 2.01990063 |
| 17 | TAOK1 | 2.00996861 |
| 18 | TAOK3 | 1.96116413 |
| 19 | CSK | 1.92725235 |
| 20 | TXK | 1.88199238 |
| 21 | IKBKE | 1.87714470 |
| 22 | BTK | 1.84744786 |
| 23 | TTN | 1.81743356 |
| 24 | JAK1 | 1.78994223 |
| 25 | ZAP70 | 1.76135669 |
| 26 | FGR | 1.75636516 |
| 27 | HCK | 1.73872515 |
| 28 | JAK3 | 1.72972032 |
| 29 | CAMK1D | 1.72254790 |
| 30 | CSF1R | 1.71300824 |
| 31 | IKBKB | 1.44058262 |
| 32 | MAP2K3 | 1.43176059 |
| 33 | SIK3 | 1.41619316 |
| 34 | LRRK2 | 1.38873124 |
| 35 | TGFBR2 | 1.37546108 |
| 36 | PTK6 | 1.36753409 |
| 37 | RIPK1 | 1.33430199 |
| 38 | SYK | 1.32943203 |
| 39 | MAP3K1 | 1.31823671 |
| 40 | CAMK1G | 1.30550968 |
| 41 | MAP3K13 | 1.30499023 |
| 42 | SIK2 | 1.28477808 |
| 43 | CDK12 | 1.28289321 |
| 44 | TEC | 1.28020608 |
| 45 | GRK6 | 1.17626008 |
| 46 | LCK | 1.15256411 |
| 47 | TAOK2 | 1.13002230 |
| 48 | PIM2 | 1.12917768 |
| 49 | PAK4 | 1.11614929 |
| 50 | PIM1 | 1.11570095 |
| 51 | MARK3 | 1.11071862 |
| 52 | KSR2 | 1.10242380 |
| 53 | TRPM7 | 1.09586818 |
| 54 | BMX | 1.09424045 |
| 55 | RPS6KA4 | 1.08211846 |
| 56 | YES1 | 1.05776492 |
| 57 | ITK | 1.03623048 |
| 58 | LYN | 1.00904446 |
| 59 | GRK7 | 0.99407683 |
| 60 | MARK2 | 0.96393551 |
| 61 | IRAK1 | 0.93211439 |
| 62 | PRKD2 | 0.90098138 |
| 63 | IRAK2 | 0.89542201 |
| 64 | JAK2 | 0.89181263 |
| 65 | MATK | 0.85640556 |
| 66 | CDC42BPA | 0.81494137 |
| 67 | CHUK | 0.79362200 |
| 68 | BMPR2 | 0.78877820 |
| 69 | MAP3K6 | 0.77597597 |
| 70 | EEF2K | 0.76464531 |
| 71 | CLK1 | 0.75787070 |
| 72 | ALK | 0.73480492 |
| 73 | TESK2 | 0.72324282 |
| 74 | EGFR | 0.70986618 |
| 75 | MAP3K11 | 0.67774145 |
| 76 | FGFR3 | 0.64315426 |
| 77 | CDK19 | 0.63914346 |
| 78 | SMG1 | 0.63680397 |
| 79 | PRKG2 | 0.63279832 |
| 80 | NEK9 | 0.62991235 |
| 81 | MAPK12 | 0.62854711 |
| 82 | MAP3K3 | 0.62203376 |
| 83 | MAPK7 | 0.60085527 |
| 84 | MAP3K10 | 0.57225820 |
| 85 | CDK6 | 0.56115047 |
| 86 | NEK2 | 0.55107101 |
| 87 | RPS6KA6 | 0.54761976 |
| 88 | ABL1 | 0.53572288 |
| 89 | MAP3K7 | 0.53239494 |
| 90 | MAP2K6 | 0.52502696 |
| 91 | MAP2K4 | 0.52362276 |
| 92 | DAPK2 | 0.51781757 |
| 93 | MST1R | 0.50812046 |
| 94 | MAPKAPK2 | 0.50104114 |
| 95 | MOS | 0.49848523 |
| 96 | EPHA3 | 0.48927899 |
| 97 | FGFR4 | 0.48894477 |
| 98 | HIPK2 | 0.48751285 |
| 99 | DYRK1B | 0.47909824 |
| 100 | CAMKK2 | 0.47596701 |
| 101 | STK4 | 0.47407765 |
| 102 | NME2 | 0.46681973 |
| 103 | RPS6KC1 | 0.46233918 |
| 104 | RPS6KL1 | 0.46233918 |
| 105 | MAP3K8 | 0.45508195 |
| 106 | PTK2 | 0.45444412 |
| 107 | MAP3K2 | 0.45046215 |
| 108 | STK11 | 0.43279667 |
| 109 | RPS6KA2 | 0.43148186 |
| 110 | FYN | 0.42478197 |
| 111 | FLT3 | 0.41881173 |
| 112 | CAMKK1 | 0.40820229 |
| 113 | STK24 | 0.40042343 |
| 114 | PRKCD | 0.39278786 |
| 115 | PDGFRB | 0.39005334 |
| 116 | STK3 | 0.39002466 |
| 117 | PDPK1 | 0.37113434 |
| 118 | CDK4 | 0.35922958 |
| 119 | MAP3K5 | 0.35864383 |
| 120 | SGK3 | 0.35686234 |
| 121 | TESK1 | 0.35155170 |
| 122 | SIK1 | 0.35043001 |
| 123 | PTK2B | 0.34871307 |
| 124 | PDK1 | 0.34731297 |
| 125 | PIK3CG | 0.34706131 |
| 126 | RET | 0.34030698 |
| 127 | MAPK4 | 0.33315841 |
| 128 | TNK2 | 0.32894370 |
| 129 | PRKCH | 0.32177782 |
| 130 | KDR | 0.31822553 |
| 131 | ABL2 | 0.31412022 |
| 132 | ACVR1B | 0.31252263 |
| 133 | KSR1 | 0.30291378 |
| 134 | PRKCQ | 0.30113566 |
| 135 | RAF1 | 0.28082053 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.50271679 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 3.37824884 |
| 3 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.58951955 |
| 4 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.40968526 |
| 5 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.25971089 |
| 6 | Other glycan degradation_Homo sapiens_hsa00511 | 2.24135885 |
| 7 | Pertussis_Homo sapiens_hsa05133 | 2.22502658 |
| 8 | Lysosome_Homo sapiens_hsa04142 | 2.14011369 |
| 9 | Tuberculosis_Homo sapiens_hsa05152 | 2.09666058 |
| 10 | Malaria_Homo sapiens_hsa05144 | 2.02817844 |
| 11 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.02360998 |
| 12 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.98824601 |
| 13 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.97456779 |
| 14 | Legionellosis_Homo sapiens_hsa05134 | 1.90657196 |
| 15 | Measles_Homo sapiens_hsa05162 | 1.86923610 |
| 16 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.83506824 |
| 17 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.82521426 |
| 18 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.74978440 |
| 19 | Shigellosis_Homo sapiens_hsa05131 | 1.69834961 |
| 20 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.68089496 |
| 21 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.64026948 |
| 22 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.63478714 |
| 23 | Influenza A_Homo sapiens_hsa05164 | 1.61494972 |
| 24 | Phagosome_Homo sapiens_hsa04145 | 1.57085780 |
| 25 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.56941630 |
| 26 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.55718774 |
| 27 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.55612952 |
| 28 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.53706878 |
| 29 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.50892786 |
| 30 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.50279384 |
| 31 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.49658148 |
| 32 | Asthma_Homo sapiens_hsa05310 | 1.48226188 |
| 33 | Salmonella infection_Homo sapiens_hsa05132 | 1.46745895 |
| 34 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.42274284 |
| 35 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.42268473 |
| 36 | Allograft rejection_Homo sapiens_hsa05330 | 1.41970688 |
| 37 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.41664121 |
| 38 | Apoptosis_Homo sapiens_hsa04210 | 1.41488444 |
| 39 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.34361095 |
| 40 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.33436556 |
| 41 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.29455674 |
| 42 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.26544596 |
| 43 | Hepatitis B_Homo sapiens_hsa05161 | 1.25566323 |
| 44 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.23324429 |
| 45 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.21393523 |
| 46 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.19685082 |
| 47 | Viral myocarditis_Homo sapiens_hsa05416 | 1.13448151 |
| 48 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.11549769 |
| 49 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.09596523 |
| 50 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.07221084 |
| 51 | Hepatitis C_Homo sapiens_hsa05160 | 1.04540335 |
| 52 | Amoebiasis_Homo sapiens_hsa05146 | 1.04248700 |
| 53 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.03847763 |
| 54 | Platelet activation_Homo sapiens_hsa04611 | 1.02388610 |
| 55 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.99800747 |
| 56 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.94957792 |
| 57 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.92786712 |
| 58 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.90700190 |
| 59 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.88650866 |
| 60 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.78551980 |
| 61 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.78386883 |
| 62 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.77708406 |
| 63 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.77653576 |
| 64 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.74276712 |
| 65 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.71643717 |
| 66 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.68142839 |
| 67 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.65323105 |
| 68 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.64855732 |
| 69 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.64160913 |
| 70 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.63715165 |
| 71 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.61883126 |
| 72 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.61083533 |
| 73 | Endocytosis_Homo sapiens_hsa04144 | 0.60039382 |
| 74 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.59439203 |
| 75 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.58612347 |
| 76 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.57357558 |
| 77 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.57129047 |
| 78 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.55990065 |
| 79 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.53805306 |
| 80 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.53055481 |
| 81 | Insulin resistance_Homo sapiens_hsa04931 | 0.50836227 |
| 82 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.49725762 |
| 83 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.48877001 |
| 84 | Focal adhesion_Homo sapiens_hsa04510 | 0.47100968 |
| 85 | HTLV-I infection_Homo sapiens_hsa05166 | 0.46710016 |
| 86 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.45904636 |
| 87 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.44991878 |
| 88 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.44157365 |
| 89 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.43119135 |
| 90 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.42888827 |
| 91 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.42802005 |
| 92 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.41727100 |
| 93 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.41405142 |
| 94 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.41385231 |
| 95 | Endometrial cancer_Homo sapiens_hsa05213 | 0.39827433 |
| 96 | Colorectal cancer_Homo sapiens_hsa05210 | 0.39370831 |
| 97 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.37081963 |
| 98 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.36219643 |
| 99 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.35696984 |
| 100 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.34965882 |
| 101 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.34598430 |
| 102 | Prostate cancer_Homo sapiens_hsa05215 | 0.34195834 |
| 103 | Glioma_Homo sapiens_hsa05214 | 0.33239795 |
| 104 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.32193176 |
| 105 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.31249437 |
| 106 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.30667570 |
| 107 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.28999727 |
| 108 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.28926835 |
| 109 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.27562776 |
| 110 | Bladder cancer_Homo sapiens_hsa05219 | 0.27128609 |
| 111 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.26147126 |
| 112 | Galactose metabolism_Homo sapiens_hsa00052 | 0.26138816 |
| 113 | Prion diseases_Homo sapiens_hsa05020 | 0.25093297 |
| 114 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.25039260 |

